Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Rx Ad Studies Target Risk Info Location, Efficacy Framing, Oncology Products

Jul 10 2017

• By Brenda Sandburg

Frame vector. Photo or picture art on vintage wall

Related Content

FDA’s Biggest DTC Advertising Study Eyes Online Promotion

Jul 08 2013

Do DTC Television Ads Really Need To List All Drug Risks?

Feb 20 2014

FDA DTC Ad Study: Firms Win Small Concession; Viewings Will Be Less Dense

Jun 17 2015

DTC And The Aging Ear: FDA Will Study Comprehension Loss

Jun 24 2015

DTC Price Comparisons To Get FDA Scrutiny

May 07 2014

DTC Animation Study Moving Forward After FDA Rejects Merck Critique

Oct 24 2016

DTC Safety Messages Could Vary By Platform As FDA Considers Screen Size

Mar 08 2016

DTC Rx Drug Ad Study No. 30: Do Market Claims Impact Perception?

Jul 29 2015

DTC Advertising For ADHD, Acne, Antidepressant Meds Could Shift After FDA Study

Jul 18 2014

DTC Ads: FDA Studying Best Ways To Do Advertising Studies

Apr 18 2014

Rx Mobile Devices Promos: Benefits Often More Prominent Than Risks

Jul 10 2017

Rx Advertising: Can Consumers And Doctors Tell When Drug Promos Are Deceptive?

Jan 03 2017

Twitter Rx Drug Promos: FDA Studies Best Way To Convey Risk Info

Nov 05 2016

TV Drug Advertising Study Targets Those With Limited Or No Internet Use

Jun 09 2017

Additional Topics

United States Advertising, Marketing & Sales Regulation Drug Safety BioPharmaceutical

More from Marketing & Advertising

More from Compliance

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window